References
- Labovitz E, Levison M E, Kaye D. Single daily-dose gentamicin therapy in urinary tract infection. Antimicrob Agents Chemother 1974; 6: 465–470
- Landes R R. Single daily doses of tobramycin in therapy of urinary tract infections. J Infect Dis 1976; 134S: 142–145
- Mosegaard A, Smith D I, Madsen P O. Single daily dosage treatment of urinary tract infections with gentamicin. Progress in chemotherapy, G K Daikos. Hellenic Society for Chemotherapy, Athens 1974; 476–481
- Herscovici L, Lemeland J F, Dalion J, Olier B, Fillastre J P. Pyélonéphrite aiguë expérimentale. Traitement par tobramycine. Influence du rythme d'administration sur l'efficacité et la tolérance rénale. Pathol Biol (Paris) 1984; 32: 450–454
- Olier B, Viotte G, Morin J P, Fillastre J P. Influence of dosage regimen on experimental tobramycin nephrotoxicity. A biochemical approach. Chemotherapy 1983; 29: 385–394
- Lowry O H, Rcsebrough N J, Fair A L, Randall R J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265–275
- Hatala M, Moravek J, Prat V, Schuck O, Liska M, Spousta J. Daily single dose gentamicin therapy in experimental pyelonephritis. Infection 1977; 5: 232–235
- Bergeron M G, Trottier S. Influence of single or multiple doses of gentamicin and netilmicin on their cortical, medullary and papillary distribution. Antimicrob Agents Chemother 1979; 15: 635–641
- Powell S H, Thompson W L, Luthe M A, Stern R C, Grossniklaus D A, Bloxham D D, Groden D L, Jacobs M R, DiScenna A O, Cash H A, Klinger J D. Once-daily vs. continuous aminoglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin and tobramycin. J Infect Dis 1983; 147: 918–931
- Arap S, Giron A, Mitre A. Traitement des infections urinaires par la tobramycine en dose quotidienne unique. Rev Bras Clin Ther 1979; 2: 265–270
- Bailey R R, Peddie B. Tobramycin in the treatment of severe and complicated urinary tract infections. Med J Aust 1977; 2: 34–37
- Limson B M, Mendoza M T. Single daily injection of tobramycin in the therapy of urinary tract infections. Philadelphia J Intern Med 1979; 17: 179–183
- Kastriostis J, Dimopoulos C. Once a day amikacin in uncomplicated urinary tract infections. Curr Ther Res 1983; 33: 445–449
- Klastersky J, Prevost J M, Meunier-Carpentier F, Daneau D, Gerard M. Comparative trial of single-dose versus twice-daily sisomicin in bacteriuric patients. J Clin Pharmacol 1977; 17: 520–528
- Dale D C, Reynolds H Y, Pennington J E, Elin R J, Pitts T W, Graw R G, Jr. Granulocyte transfusion therapy of experimental Pseudomonas pneumonia. J Clin Invest 1974; 54: 664–671
- Pennington J E, Dale D C, Reynolds H Y, MacLowry J D. Gentamicin sulfate pharmacokinetics: lower levels of gentamicin in blood during fever. J Infect Dis 1975; 132: 270–275
- Frame P T, Watanakunakorn C, Cluxton R J. Comparative nephrotoxicity of netilmicin and gentamicin in rabbits. Curr Ther Res 1978; 24: 344–348
- Reiner N E, Bloxham D D, Thompson W L. Nephrotoxicity of gentamicin and tobramycin given once daily or continuously in dogs. J Antimicrob Chemother 1978; 4: 85–101
- Bennett W M, Plamp C E, Gilbert D N, Parker R A, Porter G A. The influence of dosage regimen on experimental gentamicin nephrotoxicity: dissociation of peak serum levels from renal failure. J Infect Dis 1979; 140: 576–580
- Luft F C, Bennett W M, Gilbert D N. Experimental aminoglycoside nephrotoxicity: accomplishments and future potential. Rev infect Dis 1983; 5: 268–283, Suppl. 2